Anterior Uveitis
20
0
0
16
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
1 terminated out of 20 trials
94.1%
+7.6% vs benchmark
20%
4 trials in Phase 3/4
38%
6 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (20)
A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
PEMF: an Adjunct Therapy for Anterior Uveitis
Aqueous Humor Dynamics and Hypertensive Uveitis
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis
Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis
Acute Anterior Uveitis: Psychic Burden and Pain
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis
Quality of Life and Visual Function in Uveitis Patients
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis